163 related articles for article (PubMed ID: 36596765)
1. NF-κB/RelA controlled A20 limits TRAIL-induced apoptosis in pancreatic cancer.
Geismann C; Hauser C; Grohmann F; Schneeweis C; Bölter N; Gundlach JP; Schneider G; Röcken C; Meinhardt C; Schäfer H; Schreiber S; Arlt A
Cell Death Dis; 2023 Jan; 14(1):3. PubMed ID: 36596765
[TBL] [Abstract][Full Text] [Related]
2. c-Rel is a critical mediator of NF-κB-dependent TRAIL resistance of pancreatic cancer cells.
Geismann C; Grohmann F; Sebens S; Wirths G; Dreher A; Häsler R; Rosenstiel P; Hauser C; Egberts JH; Trauzold A; Schneider G; Sipos B; Zeissig S; Schreiber S; Schäfer H; Arlt A
Cell Death Dis; 2014 Oct; 5(10):e1455. PubMed ID: 25299780
[TBL] [Abstract][Full Text] [Related]
3. Role of CCL20 mediated immune cell recruitment in NF-κB mediated TRAIL resistance of pancreatic cancer.
Geismann C; Grohmann F; Dreher A; Häsler R; Rosenstiel P; Legler K; Hauser C; Egberts JH; Sipos B; Schreiber S; Linkermann A; Hassan Z; Schneider G; Schäfer H; Arlt A
Biochim Biophys Acta Mol Cell Res; 2017 May; 1864(5):782-796. PubMed ID: 28188806
[TBL] [Abstract][Full Text] [Related]
4. TRAIL/NF-κB/CX3CL1 Mediated Onco-Immuno Crosstalk Leading to TRAIL Resistance of Pancreatic Cancer Cell Lines.
Geismann C; Erhart W; Grohmann F; Schreiber S; Schneider G; Schäfer H; Arlt A
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29867042
[TBL] [Abstract][Full Text] [Related]
5. Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells.
Ma Z; Vocadlo DJ; Vosseller K
J Biol Chem; 2013 May; 288(21):15121-30. PubMed ID: 23592772
[TBL] [Abstract][Full Text] [Related]
6. Differential activity of GSK-3 isoforms regulates NF-κB and TRAIL- or TNFα induced apoptosis in pancreatic cancer cells.
Zhang JS; Herreros-Villanueva M; Koenig A; Deng Z; de Narvajas AA; Gomez TS; Meng X; Bujanda L; Ellenrieder V; Li XK; Kaufmann SH; Billadeau DD
Cell Death Dis; 2014 Mar; 5(3):e1142. PubMed ID: 24675460
[TBL] [Abstract][Full Text] [Related]
7. The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity.
Lai SW; Bamodu OA; Tsai WC; Chang YM; Lee WH; Yeh CT; Chao TY
Clin Exp Metastasis; 2018 Oct; 35(7):663-677. PubMed ID: 29987671
[TBL] [Abstract][Full Text] [Related]
8. Selective targeting of the nuclear factor-kappaB pathway enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated pancreatic cancer cell death.
Thomas RP; Farrow BJ; Kim S; May MJ; Hellmich MR; Evers BM
Surgery; 2002 Aug; 132(2):127-34. PubMed ID: 12219002
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of the E3-ubiquitin ligase receptor subunit betaTRCP1 relates to constitutive nuclear factor-kappaB activation and chemoresistance in pancreatic carcinoma cells.
Müerköster S; Arlt A; Sipos B; Witt M; Grossmann M; Klöppel G; Kalthoff H; Fölsch UR; Schäfer H
Cancer Res; 2005 Feb; 65(4):1316-24. PubMed ID: 15735017
[TBL] [Abstract][Full Text] [Related]
10. SKP2 confers resistance of pancreatic cancer cells towards TRAIL-induced apoptosis.
Schüler S; Diersch S; Hamacher R; Schmid RM; Saur D; Schneider G
Int J Oncol; 2011 Jan; 38(1):219-25. PubMed ID: 21109943
[TBL] [Abstract][Full Text] [Related]
11. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
Chen X; Kandasamy K; Srivastava RK
Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723
[TBL] [Abstract][Full Text] [Related]
12. Nuclear factor-kappaB maintains TRAIL resistance in human pancreatic cancer cells.
Khanbolooki S; Nawrocki ST; Arumugam T; Andtbacka R; Pino MS; Kurzrock R; Logsdon CD; Abbruzzese JL; McConkey DJ
Mol Cancer Ther; 2006 Sep; 5(9):2251-60. PubMed ID: 16985059
[TBL] [Abstract][Full Text] [Related]
13. Glutamine-mediated epigenetic regulation of cFLIP underlies resistance to TRAIL in pancreatic cancer.
Kim JH; Lee J; Im SS; Kim B; Kim EY; Min HJ; Heo J; Chang EJ; Choi KC; Shin DM; Son J
Exp Mol Med; 2024 Apr; 56(4):1013-1026. PubMed ID: 38684915
[TBL] [Abstract][Full Text] [Related]
14. NEMO peptide inhibits the growth of pancreatic ductal adenocarcinoma by blocking NF-κB activation.
Zhuang Z; Li H; Lee H; Aguilar M; Gocho T; Ju H; Iida T; Ling J; Fu J; Wu M; Sun Y; Lu Y; Chiao PJ
Cancer Lett; 2017 Dec; 411():44-56. PubMed ID: 28951128
[TBL] [Abstract][Full Text] [Related]
15. The novel TRAIL-receptor agonist APG350 exerts superior therapeutic activity in pancreatic cancer cells.
Legler K; Hauser C; Egberts JH; Willms A; Heneweer C; Boretius S; Röcken C; Glüer CC; Becker T; Kluge M; Hill O; Gieffers C; Fricke H; Kalthoff H; Lemke J; Trauzold A
Cell Death Dis; 2018 May; 9(5):445. PubMed ID: 29670075
[TBL] [Abstract][Full Text] [Related]
16. A20 ubiquitin ligase-mediated polyubiquitination of RIP1 inhibits caspase-8 cleavage and TRAIL-induced apoptosis in glioblastoma.
Bellail AC; Olson JJ; Yang X; Chen ZJ; Hao C
Cancer Discov; 2012 Feb; 2(2):140-55. PubMed ID: 22585859
[TBL] [Abstract][Full Text] [Related]
17. Advancement of NF-κB Signaling Pathway: A Novel Target in Pancreatic Cancer.
Pramanik KC; Makena MR; Bhowmick K; Pandey MK
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30563089
[TBL] [Abstract][Full Text] [Related]
18. Mutations in K-Ras linked to levels of osteoprotegerin and sensitivity to TRAIL-induced cell death in pancreatic ductal adenocarcinoma cells.
Kanzaki H; Ohtaki A; Merchant FK; Greene MI; Murali R
Exp Mol Pathol; 2013 Apr; 94(2):372-9. PubMed ID: 23219833
[TBL] [Abstract][Full Text] [Related]
19. MiR-125a regulates chemo-sensitivity to gemcitabine in human pancreatic cancer cells through targeting A20.
Yao J; Li Z; Wang X; Xu P; Zhao L; Qian J
Acta Biochim Biophys Sin (Shanghai); 2016 Feb; 48(2):202-8. PubMed ID: 26758190
[TBL] [Abstract][Full Text] [Related]
20. TRAIL-mediated apoptosis requires NF-kappaB inhibition and the mitochondrial permeability transition in human hepatoma cells.
Kim YS; Schwabe RF; Qian T; Lemasters JJ; Brenner DA
Hepatology; 2002 Dec; 36(6):1498-508. PubMed ID: 12447876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
